Effect of site of venous protamine administration, previously alleged risk factors, and preoperative use of aspirin on acute protamine-induced pulmonary vasoconstriction

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 17, Issue 3, 2003, Pages 309-313

  Comunale, Mark E ^a   Maslow, Andrew ^b   Robertson, Linda K ^b   Haering, J Michael ^b   Mashikian, John S ^b   Lowenstein, Edward ^b  

^a SAINT LOUIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

Aspirin; Heparin; Protamine; Pulmonary vasoconstriction; Thromboxane

Indexed keywords

ACETYLSALICYLIC ACID; FENTANYL DERIVATIVE; HEPARIN DERIVATIVE; ISOFLURANE; PROTAMINE; THIOPENTAL; THROMBOXANE;

ADULT; AGED; ANESTHESIOLOGICAL TECHNIQUES; ARTICLE; CARDIOPULMONARY BYPASS; CENTRAL VEIN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEMOGRAPHY; DRUG EFFECT; DRUG INFUSION; FEMALE; FOOD ALLERGY; HEART RIGHT VENTRICLE FUNCTION; HEPARINIZATION; HUMAN; HYPOTENSION; LUNG ARTERY PRESSURE; LUNG VASOCONSTRICTION; MAJOR CLINICAL STUDY; MALE; PERIPHERAL VEIN; PREOPERATIVE PERIOD; PRIORITY JOURNAL; PROSPECTIVE STUDY; PULMONARY HYPERTENSION; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; VASECTOMY;

EID: 0038121880     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1053-0770(03)00055-7     Document Type: Article

References (27)

1. Lowenstein E, Johnston WE, Demetrios GL, et al: Catastrophic pulmonary vasoconstriction associated with protamine reversal of heparin. Anesthesiology 59:470-473, 1983
2. Horrow JC: Heparin reversal of protamine toxicity: Have we come full circle? J Cardiothorac Vasc Anesth 4:539, 1990
3. Lowenstein E: Lessons from studying an infrequent event: Adverse hemodynamic response associated with protamine reversal of heparin anticoagulation. J Cardiothorac Vasc Anesth 3:99-107, 1989
4. Morel DR, Lowenstein E, Nguyenduy T, et al: Acute pulmonary vasoconstriction and thromboxane release during protamine reversal of heparin anticoagulation in awake sheep. Circ Res 62:905-915, 1988
5. Montalescot G, Lowenstein E, Ogletree ML, et al: Thromboxane receptor blockade prevents pulmonary hypertension induced by heparin-protamine reactions in awake sheep. Circulation 82:1765-1777, 1990
6. Nuttall GA, Murray MJ, Bowie EJ: Protamine-heparin-induced pulmonary hypertension in pigs: Effects of treatment with a thromboxane receptor antagonist on hemodynamics and coagulation. Anesthesiology 74:138-145, 1991
7. Lowenstein E, Zapol WM: Protamine reactions, explosive mediator release, and pulmonary vasoconstriction. Anesthesiology 73:373-375, 1990
8. Pauca AL, Graham JE, Hudspeth AS: Hemodynamic effects of intraaortic administration of protamine. Ann Thorac Surg 35:637-642, 1983
9. Katz NM, Kim YD, Siegelman R, et al: Hemodynamics of protamine administration. J Thorac Cardiovasc Surg 94:881-886, 1987
10. Procachini B, Clementi G, Bersanetti L, et al: Cardiorespiratory effects of protamine sulphate in man: Intra-aortic vs intra-right atrial rapid administration after cardiopulmonary bypass. J Cardiovasc Surg 28:112-119, 1987
11. Ovrum E, Lindberg H, Holen EA, et al: Hemodynamic effects of intraaortic versus intravenous protamine administration after cardiopulmonary bypass in man. Scand J Thor Cardiovasc Surg 26:113-118, 1992
12. Milne B, Rogers K, Cervenko F, et al: The haemodynamic effects of intraaortic versus intravenous administration of protamine for reversal of heparin in man. Can Anaesth Soc J 30:347-351, 1983
13. Suwanchinda V, Prakanrattana U: Comparison of the hemodynamic changes following left atrial and peripheral venous administration of protamine during cardiac surgery. J Med Assoc Thai 72:303-306, 1989
14. Morel DR, Mo Costabella PM, Pittet JF: Adverse cardiopulmonary effects and increased plasma thromboxane concentrations following the neutralization of heparin with protamine in awake sheep are infusion rate-dependent. Anesthesiology 73:415-424, 1990
15. Frater RW, Oka Y, Hong Y, et al: Protamine-induced circulatory changes. J Thorac Cardiovasc Surg 87:687-693, 1984
16. Lowenstein E, Lynch K, Robinson DR, et al: Incidence, severity and causation of adverse cardiopulmonary response to protamine reversal of heparin anticoagulation in man. Am Rev Respir Dis 137: A245, 1988 (abstr)
17. Shanberge JN, Murato M, Quatrociocchi-Lange T, et al: Heparin-protamine complexes in the production of heparin rebound and other complications of extracorporeal bypass procedures. Am J Clin Pathol 87:210-217, 1987
18. Kessler CM: The pharmacology of aspirin, heparin, coumarin, and thrombolytic agents. Chest 99:97S-112S, 1991
19. Theroux P, Ouimet H, McCans J, et al: Aspirin, heparin, or both to treat acute unstable angina. N Engl J Med 17:1105-1111, 1988
20. Merlini PA, Bauer KA, Oltrona L, et al: Persistent activation of coagulation mechanism in unstable angina and myocardial infarction. Circulation 90:61-68, 1994
21. Montalescot G, Philippe F, Ankri A, et al: Early increase of von Willebrand factor predicts adverse outcome in unstable coronary artery disease. Circulation 98:294-299, 1998
22. Fuster V, Badimon L, Badimon JJ, et al: The pathogenesis of coronary artery disease and the acute coronary syndromes (first of two parts). N Engl J Med 326:242-250, 1992
23. Fuster V, Badimon L, Badimon JJ, et al: The pathogenesis of coronary artery disease and the acute coronary syndromes (second of two parts). N Engl J Med 326:310-318, 1992
24. Vincent GM, Janowsici M, Menlove R: Protamine allergy reactions during cardiac catheterization and cardiac surgery: Risk in patients taking protamine-insulin preparations. Cathet Cardiovasc Diagn 23:164-168, 1991
25. Concato J, Shan N, Horwitz R: Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med 342:1887-1892, 2000
26. Benson K, Hartz AJ: A comparison of observational studies and randomized, controlled trials. N Engl J Med 342:1878-1886, 2000
27. Bailar JC, Louis TA, Lavori PW, et al: Studies without internal controls. N Engl J Med 311:156-162, 1984